MicroRNAs As Effectors of Brain Function with Roles in Ischemia and Injury, Neuroprotection, and Neurodegeneration

Overview

Journal J Cereb Blood Flow Metab

Publisher Sage Publications

Specialties Cardiology & Vascular Diseases
Endocrinology
Neurology

Date 2010 Jul 8

PMID 20606686

Citations 131

Authors

Julie A Saugstad

Affiliations

Soon will be listed here.

Abstract

MicroRNAs are small RNAs that function as regulators of posttranscriptional gene expression. MicroRNAs are encoded by genes, and processed to form ribonucleoprotein complexes that bind to messenger RNA (mRNA) targets to repress translation or degrade mRNA transcripts. The microRNAs are particularly abundant in the brain where they serve as effectors of neuronal development and maintenance of the neuronal phenotype. They are also expressed in dendrites where they regulate spine structure and function as effectors in synaptic plasticity. MicroRNAs have been evaluated for their roles in brain ischemia, traumatic brain injury, and spinal cord injury, and in functional recovery after ischemia. They also serve as mediators in the brain's response to ischemic preconditioning that leads to endogenous neuroprotection. In addition, microRNAs are implicated in neurodegenerative disorders, including Alzheimer's, Huntington, Parkinson, and Prion disease. The discovery of microRNAs has expanded the potential for human diseases to arise from genetic mutations in microRNA genes or sequences within their target mRNAs. This review discusses microRNA discovery, biogenesis, mechanisms of gene regulation, their expression and function in the brain, and their roles in brain ischemia and injury, neuroprotection, and neurodegeneration.

Citing Articles

The miR-451a facilitates natural killer cell-associated immune deficiency after ischemic stroke.

Li Y, Guan X, Lan T, Zhang Z, Zhang Y, Jiang S J Cereb Blood Flow Metab. 2025; :271678X251321641.

PMID: 39985210 PMC: 11846095. DOI: 10.1177/0271678X251321641.

Cross-disease transcriptomic analysis reveals DOK3 and PAPOLA as therapeutic targets for neuroinflammatory and tumorigenic processes.

Wang X, Bian Y, Chen W Front Immunol. 2024; 15:1504629.

PMID: 39726593 PMC: 11669587. DOI: 10.3389/fimmu.2024.1504629.

Anti-miRNA103/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage.

Cepparulo P, Cuomo O, Campani V, Vinciguerra A, Sisalli M, Nele V Mol Ther Nucleic Acids. 2024; 35(1):102131.

PMID: 38379726 PMC: 10877170. DOI: 10.1016/j.omtn.2024.102131.

Small RNA-big impact: exosomal miRNAs in mitochondrial dysfunction in various diseases.

Li X, Han Y, Meng Y, Yin L RNA Biol. 2024; 21(1):1-20.

PMID: 38174992 PMC: 10773649. DOI: 10.1080/15476286.2023.2293343.

MiR-30c-5p-Targeted Regulation of GNAI2 Improves Neural Function Injury and Inflammation in Cerebral Ischemia-Reperfusion Injury.

Deng X, Zeng Y, Ding D Appl Biochem Biotechnol. 2023; 196(8):5235-5248.

PMID: 38153649 DOI: 10.1007/s12010-023-04802-5.

References

Ghildiyal M, Zamore P . Small silencing RNAs: an expanding universe. Nat Rev Genet. 2009; 10(2):94-108. PMC: 2724769. DOI: 10.1038/nrg2504. View

Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

Alexiou P, Maragkakis M, Papadopoulos G, Reczko M, Hatzigeorgiou A . Lost in translation: an assessment and perspective for computational microRNA target identification. Bioinformatics. 2009; 25(23):3049-55. DOI: 10.1093/bioinformatics/btp565. View

Yin K, Deng Z, Huang H, Hamblin M, Xie C, Zhang J . miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis. 2010; 38(1):17-26. PMC: 2837803. DOI: 10.1016/j.nbd.2009.12.021. View

Pillai R, Bhattacharyya S, Filipowicz W . Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol. 2007; 17(3):118-26. DOI: 10.1016/j.tcb.2006.12.007. View

Lukiw W, Zhao Y, Cui J . An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem. 2008; 283(46):31315-22. PMC: 2581572. DOI: 10.1074/jbc.M805371200. View

Lim L, Lau N, Garrett-Engele P, Grimson A, Schelter J, Castle J . Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005; 433(7027):769-73. DOI: 10.1038/nature03315. View

Chong J, Tapia-Ramirez J, Kim S, Toledo-Aral J, Zheng Y, Boutros M . REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell. 1995; 80(6):949-57. DOI: 10.1016/0092-8674(95)90298-8. View

Sempere L, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V . Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004; 5(3):R13. PMC: 395763. DOI: 10.1186/gb-2004-5-3-r13. View

10.

Rademakers R, Rovelet-Lecrux A . Recent insights into the molecular genetics of dementia. Trends Neurosci. 2009; 32(8):451-61. PMC: 2864783. DOI: 10.1016/j.tins.2009.05.005. View

11.

Okamura K, Lai E . Endogenous small interfering RNAs in animals. Nat Rev Mol Cell Biol. 2008; 9(9):673-8. PMC: 2729316. DOI: 10.1038/nrm2479. View

12.

Packer A, Xing Y, Harper S, Jones L, Davidson B . The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci. 2009; 28(53):14341-6. PMC: 3124002. DOI: 10.1523/JNEUROSCI.2390-08.2008. View

13.

Vo N, Klein M, Varlamova O, Keller D, Yamamoto T, Goodman R . A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A. 2005; 102(45):16426-31. PMC: 1283476. DOI: 10.1073/pnas.0508448102. View

14.

Chahrour M, Jung S, Shaw C, Zhou X, Wong S, Qin J . MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008; 320(5880):1224-9. PMC: 2443785. DOI: 10.1126/science.1153252. View

15.

Johnson R, Zuccato C, Belyaev N, Guest D, Cattaneo E, Buckley N . A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis. 2007; 29(3):438-45. DOI: 10.1016/j.nbd.2007.11.001. View

16.

Tsai N, Lin Y, Wei L . MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem J. 2009; 424(3):411-8. DOI: 10.1042/BJ20090915. View

17.

Gebauer F, Hentze M . Molecular mechanisms of translational control. Nat Rev Mol Cell Biol. 2004; 5(10):827-35. PMC: 7097087. DOI: 10.1038/nrm1488. View

18.

Park C, Tang S . Regulation of microRNA expression by induction of bidirectional synaptic plasticity. J Mol Neurosci. 2008; 38(1):50-6. DOI: 10.1007/s12031-008-9158-3. View

19.

Redell J, Liu Y, Dash P . Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes. J Neurosci Res. 2008; 87(6):1435-48. PMC: 5980641. DOI: 10.1002/jnr.21945. View

20.

John B, Enright A, Aravin A, Tuschl T, Sander C, Marks D . Human MicroRNA targets. PLoS Biol. 2004; 2(11):e363. PMC: 521178. DOI: 10.1371/journal.pbio.0020363. View